17 Jul 2023
4m
Eli Lilly CEO: Alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
CNBC Television
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.